Related Experiment Video
Updated: Jun 24, 2025

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
Focal cortical dysplasia II caused by brain somatic mutation of IRS-1 is associated with ERK signaling pathway
Xiao Li1,2,3, Tianshuang Wang4, Nana Liu1,2,3
1Department of Pediatrics, Peking University First Hospital, No. 1 Xi'an Men Street, West District, Beijing 100034, China.
Abstract:
Somatic mutations have been identified in 10% to 63% of focal cortical dysplasia type II samples, primarily linked to the mTOR pathway. When the causative genetic mutations are not identified, this opens the possibility of discovering new pathogenic genes or pathways that could be contributing to the condition. In our previous study, we identified a novel candidate pathogenic somatic variant of IRS-1 c.1791dupG in the brain tissue of a child with focal cortical dysplasia type II. This study further explored the variant's role in causing type II focal cortical dysplasia through in vitro overexpression in 293T and SH-SY5Y cells and in vivo evaluation via in utero electroporation in fetal brains, assessing effects on neuronal migration, morphology, and network integrity. It was found that the mutant IRS-1 variant led to hyperactivity of p-ERK, increased cell volume, and was predominantly associated with the MAPK signaling pathway. In vivo, the IRS-1 c.1791dupG variant induced abnormal neuron migration, cytomegaly, and network hyperexcitability. Notably, the ERK inhibitor GDC-0994, rather than the mTOR inhibitor rapamycin, effectively rescued the neuronal defects. This study directly highlighted the ERK signaling pathway's role in the pathogenesis of focal cortical dysplasia II and provided a new therapeutic target for cases of focal cortical dysplasia II that are not treatable by rapamycin analogs.
Insights
A novel IRS-1 gene variant causes focal cortical dysplasia type II by activating the ERK pathway, leading to abnormal neuron development. Targeting ERK, not mTOR, may treat these cases.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Focal cortical dysplasia type II (FCDII) involves somatic mutations, often in the mTOR pathway.
- Unidentified mutations suggest novel pathogenic genes or pathways in FCDII.
- A prior study identified a candidate IRS-1 c.1791dupG somatic variant in FCDII.
Purpose of the Study:
- To investigate the role of the IRS-1 c.1791dupG variant in FCDII pathogenesis.
- To explore the effects of the variant on neuronal development and signaling pathways.
- To identify potential therapeutic targets for FCDII.
Main Methods:
- In vitro overexpression studies in 293T and SH-SY5Y cells.
- In vivo evaluation using in utero electroporation in fetal brains.
- Assessment of neuronal migration, morphology, network integrity, and signaling pathway activity (p-ERK, MAPK).
Main Results:
- The IRS-1 c.1791dupG variant caused hyperactivity of p-ERK and increased cell volume, implicating the MAPK pathway.
- In vivo, the variant led to abnormal neuron migration, cytomegaly, and network hyperexcitability.
- The ERK inhibitor GDC-0994, but not the mTOR inhibitor rapamycin, rescued the observed neuronal defects.
Conclusions:
- The ERK signaling pathway is directly implicated in the pathogenesis of FCDII.
- The IRS-1 c.1791dupG variant contributes to FCDII through MAPK pathway activation.
- Targeting the ERK pathway offers a potential therapeutic strategy for specific FCDII cases.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

